Concepedia

Author

Stephen P. Hoole

Papworth HospitalORCID

Also Known As

Hoole, Stephen P, Hoole, Stephen P., M. Henein, Mark Harbinson, Nick Palmer, S HOOLE, S Hoole, S P Hoole, S. Hoole, S. Rekhraj

293

Publications

6.8K

Citations

38

H-Index

64

Concepts

All Affiliations

Papworth HospitalUniversity of CambridgePapworth Hospital NHS Foundation TrustAddenbrooke's HospitalCambridge University Hospitals NHS Foundation Trust
SP

About

Stephen P. Hoole is an author at Papworth Hospital specializing in cardiovascular disease, medicine, and cardiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

13

1.6K

2

Public Health

4

4

165

3

Engineering

1

1

11

4

Health Sciences

1

1

233

5

Biomedical Engineering

1

1

11

Stephen P. Hoole

×

67

Publications

5.6K

Citations

36

H-Index

YearCitations

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni,

The Lancet

2018

761

European Society of Cardiology, acute cardiovascular care association, SCAD study group: a position paper on spontaneous coronary artery dissection

David Adlam, Fernándo Alfonso, Angela H.E.M. Maas,

European Heart Journal

2018

627

Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study

Stephen P. Hoole, Patrick M. Heck, Linda Sharples,

Circulation

2009

432

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

Derek J. Hausenloy, Rajesh Kharbanda, Ulla Møller,

The Lancet

2019

309

Long-Term Durability of Transcatheter Aortic Valve Prostheses

Daniel J. Blackman, Smriti Saraf, Philip MacCarthy,

Journal of the American College of Cardiology

2019

253

Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure

Stefan James, David Erlinge, Robert F. Storey,

NEJM Evidence

2023

233

DPP-4 Inhibition by Sitagliptin Improves the Myocardial Response to Dobutamine Stress and Mitigates Stunning in a Pilot Study of Patients With Coronary Artery Disease

Philip A. Read, Fakhar Z. Khan, Patrick M. Heck,

Circulation Cardiovascular Imaging

2010

227

Remote Ischemic Preconditioning Improves Outcome at 6 Years After Elective Percutaneous Coronary Intervention

William R. Davies, Adam J. Brown, W. D. Watson,

Circulation Cardiovascular Interventions

2013

162

Atherosclerotic Plaque Composition and Classification Identified by Coronary Computed Tomography

Daniel R. Obaid, Patrick A. Calvert, Deepa Gopalan,

Circulation Cardiovascular Imaging

2013

122

A Pilot Study to Assess Whether Glucagon-Like Peptide-1 Protects the Heart From Ischemic Dysfunction and Attenuates Stunning After Coronary Balloon Occlusion in Humans

Philip A. Read, Stephen P. Hoole, Paul A. White,

Circulation Cardiovascular Interventions

2011

119

Page 1